Blog
SpeciCare
For more than 35 years, Ken Dixon, M.D., FACS, a surgeon with Surgical Oncology of Northeast Georgia, has treated cancer patients in his practice located in Gainesville, Ga. After a lifetime taking care of cancer patients, and telling a patient or a family member ‘there is nothing left to do’ Dr. Dixon began a journey to do more. Hear more of Dr. Dixon’s thoughts directly from him from this blog.
Cancer Biopsy Options
Cancer Biopsy Options Why Cryopreservation is the New Standard URL Slug: /cancer-biopsy-options-cryopreservation/ Meta Title: Cancer Biopsy Options: Why Live Tissue Preservation Matters Meta Description: Explore cancer biopsy options like cryopreservation. Learn how...
How $900 Completely Changes Cancer Care
The $900 Cancer Game Changer How Cryopreservation Could Save Your Life When you hear the word "biopsy," your mind immediately jumps to results. Will it be cancer? What stage? What's the treatment plan? But there's a critical question most patients never think to ask -...
How AI is Changing Cancer Care for 2026
AI-Powered Cancer Care Why Forward-Thinking Patients Are Demanding Precision Testing Before Treatment The statistics are sobering: approximately 50% of first-time cancer treatments fail. After months of grueling chemotherapy, radiation, or targeted therapy, half of...
1 in 3 Americans Will Get Cancer & 1 in 2 Will Get the Wrong Treatment
The Sad Truth About “Standard” Cancer Treatment Why Testing Before Treatment can change everything If you or someone you love has just heard the word cancer, the next question usually comes fast: “What do we do next?” Most patients assume the answer will be precise....
3 Tests are Dramatically Changing the Way We Fight Cancer
Three Advanced Cancer Tests Most Patients Never Hear About—and Why Tissue Preservation Comes First In the United States, cancer is not a rare event—it’s a common life chapter for far too many families. Depending on how you count and which population statistics you...
Why Billions are Being Invested in the Future of Cancer Care
Cancer care is in the middle of a quiet revolution—and the smartest money in healthcare has noticed. In the last few weeks alone: Abbott announced a ~$21–23 billion acquisition of Exact Sciences, the company behind Cologuard and major precision-oncology assays like...